Table 1.
Sex | Hand | Age | AOS | DUP | Meds | Cpzeq | FSIQ | Pos | Neg |
---|---|---|---|---|---|---|---|---|---|
M | 0 | 17.61 | 16.5 | 1.1 | Ol | 300 | 78 | 23 | 23 |
M | −55 | 17.58 | 15.3 | 2.27 | Ol | 200 | N/A | 23 | 15 |
M | −68 | 16.46 | 15.7 | 0.75 | Ol | 200 | 97 | 27 | 17 |
M | 90 | 17.68 | 16.8 | 0.87 | Ol | 400 | 68 | 22 | 15 |
M | 100 | 15.21 | 14.6 | 0.61 | Ol | 300 | 102 | 24 | 13 |
M | 100 | 16.41 | 15.8 | 0.59 | Ol | 400 | 85 | 23 | 15 |
M | 100 | 17.05 | 15.7 | 1.34 | Ol | 200 | 104 | 24 | 9 |
M | 80 | 14.99 | 13.5 | 1.48 | Ol | 400 | 85 | 26 | 18 |
M | 70 | 15.98 | 14 | 1.96 | Clz | 500 | 72 | 22 | 23 |
M | 80 | 15.18 | 13 | 2.17 | Que, Ol | 748 | 74 | 22 | 15 |
M | 50 | 16.76 | 15.25 | 1.5 | Ol | 250 | 84 | 23 | 13 |
M | 100 | 17.17 | 14.5 | 2.66 | Clz | 600 | 66 | 25 | 20 |
M | 90 | 16.89 | 14 | 2.88 | Que | 192 | 113 | 17 | 13 |
M | −25 | 14.37 | 13 | 2.36 | Ol | 200 | 66 | 21 | 17 |
M | 100 | 16.47 | 14.47 | 2 | Ris | 150 | 73 | 24 | 11 |
M | 100 | 16.83 | 16 | 0.83 | Ol, Ris | 250 | 108 | 22 | 17 |
M | 100 | 14.95 | 14 | 0.95 | Arp, Ris | 300 | 85 | 19 | 14 |
M | −60 | 16.98 | 15.9 | 1.08 | Ol | 200 | 73 | 21 | 17 |
M | 100 | 16.88 | 11 | 5.88 | Arp, Ris | 550 | N/A | 26 | 22 |
M | 100 | 16.28 | 15.6 | 0.65 | Flo, Ol | 250 | 71 | 21 | 15 |
M | 100 | 17.69 | 16.7 | 1 | Ris | 200 | 117 | 23 | 16 |
M | 80 | 16.65 | 16 | 0.6 | Ol | 150 | 102 | 22 | 14 |
F | 100 | 17.01 | 15 | 2 | Ol | 400 | N/A | 27 | 17 |
F | 100 | 15.7 | 14.9 | 0.79 | Ol | 300 | 101 | 26 | 15 |
F | 100 | 16.99 | 15.9 | 1.08 | Clz | 350 | 86 | 20 | 16 |
F | −70 | 15.89 | 14.75 | 1.13 | Ol, Que, Clz | 730 | 73 | 21 | 13 |
F | 100 | 16.38 | 12 | 4.36 | Sul | 67 | 120 | 20 | 16 |
F | 80 | 16.09 | 15.3 | 0.79 | Clz, Ol | 1000 | 80 | 18 | 16 |
F | 100 | 14.14 | 12 | 2.4 | Clz | 900 | 62 | 23 | 18 |
F | 100 | 17.38 | 12 | 5.8 | Clz | 750 | 100 | 24 | 12 |
F | 54 | 15.56 | 14.6 | 0.95 | Ol | 200 | 117 | 17 | 12 |
F | 95 | 17.08 | 16 | 1.08 | Que, Al | 384 | 84 | 20 | 15 |
F | 100 | 16.77 | 13 | 3.77 | Que, Al | 668 | 88 | 24 | 15 |
F | 0 | 16.73 | 11 | 5.73 | Ris, Al | 300 | 81 | 24 | 13 |
F | 100 | 16.78 | 12.7 | 4.08 | Que | 448 | 107 | 24 | 19 |
F | 100 | 16.19 | 15 | 1.19 | Ris | 200 | 87 | 22 | 19 |
F | −80 | 14.42 | 13.6 | 0.84 | Ris | 150 | 85 | 29 | 18 |
F | −100 | 15.08 | 14 | 1 | Ris | 150 | 75 | 18 | 12 |
F | 100 | 14.4 | 13.5 | 0.9 | Arp | 100 | 96 | 21 | 14 |
Hand = handedness score (Edinburgh handedness inventory); Age = age at scan (years); AOS = age at the onset of symptoms (years); DUP = duration of untreated psychosis; Cpzeq = dosage in chlorpromazine equivalent (mg per day); FSIQ = full-scale intelligence quotient; Pos = positive PANSS symptom score; Neg = negative PANSS symptom score; Meds = medication, where Ol = olanzapine; Que = quetiapine; Ris = risperidone; Clz = clozapine; Arp = aripiprazole; Flo = fluoxetine; Al = sodium valproate; Sul = sulpiride; N/A = not available.